1801343-74-7
1801343-74-7
Chemical Structure
IRAK4-IN-7
- CAS. Nr.: 1801343-74-7
- Formula:C21H19N7O3
- Molecular Weight:417.42
IUPAC Name: 6'-amino-N-(2-morpholinooxazolo[4,5-b]pyridin-6-yl)-[2,3'-bipyridine]-6-carboxamide
InChIKey: RWIMETUXCNDSLE-UHFFFAOYSA-N
SMILES: O=C(C1=CC=CC(C2=CC=C(N)N=C2)=N1)NC3=CN=C4C(OC(N5CCOCC5)=N4)=C3
Biological Activity: IRAK4-IN-7 is a selective, potent and orally active interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, extracted from patent WO2015104688 (example 1). IRAK4-IN-7 has the potential for cancer and inflammatory diseases treatment[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
IRAK4-IN-7 | 99.36% | IRAK4-IN-7 is a selective, potent and orally active interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, extracted from patent WO2015104688 (example 1). IRAK4-IN-7 has the potential for cancer and inflammatory diseases treatment. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
IRAK4-IN-7 (Standard) | ≥98% | IRAK4-IN-7 (Standard) is the analytical standard of IRAK4-IN-7 (HY-109585). This product is intended for research and analytical applications. IRAK4-IN-7 is a selective, potent and orally active interleuKin-1 receptor-associated Kinase 4 (IRAK4) inhibitor, extracted from patent WO2015104688 (example 1). IRAK4-IN-7 has the potential for cancer and inflammatory diseases treatment. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
